{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T04:33:16Z","timestamp":1720931596755},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00280-014-2557-y","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T21:16:03Z","timestamp":1407964563000},"page":"847-860","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma"],"prefix":"10.1007","volume":"74","author":[{"given":"Ana S.","family":"Soares","sequence":"first","affiliation":[]},{"given":"Vera M.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Diniz","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Fresco","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"2557_CR1","doi-asserted-by":"crossref","unstructured":"Bandarchi B, Ma L, Navab R, Seth A, Rasty G (2010) From melanocyte to metastatic malignant melanoma. Dermatol Res Pract 2010. doi: 10.1155\/2010\/583748","DOI":"10.1155\/2010\/583748"},{"issue":"5","key":"2557_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277\u2013300","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2557_CR3","first-page":"488","volume":"23","author":"S Bhatia","year":"2009","unstructured":"Bhatia S, Tykodi SS, Thompson JA (2009) Treatment of metastatic melanoma: an overview. Oncology 23(6):488\u2013496","journal-title":"Oncology"},{"issue":"8","key":"2557_CR4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopha.2013.08.003","volume":"67","author":"AS Soares","year":"2013","unstructured":"Soares AS, Costa VM, Diniz C, Fresco P (2013) Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: a new possible therapeutic strategy for melanoma. Biomed Pharmacother 67(8):777\u2013789","journal-title":"Biomed Pharmacother"},{"key":"2557_CR5","author":"AS Soares","year":"2014","unstructured":"Soares AS, Costa VM, Diniz C, Fresco P (2014) Combination of Cl-IB-MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR-dependent autophagy and mitotic catastrophe on human melanoma cells. J Cancer Res Clin Oncol. doi: 10.1007\/s00432-014-1645-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"2557_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1479-5876-10-53","volume":"10","author":"G Madonna","year":"2012","unstructured":"Madonna G, Ullman CD, Gentilcore G, Palmieri G, Ascierto PA (2012) NF-kappaB as potential target in the treatment of melanoma. J Transl Med 10:53. doi: 10.1186\/1479-5876-10-53","journal-title":"J Transl Med"},{"issue":"2","key":"2557_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1087-0024.2005.200407.x","volume":"10","author":"NK Haass","year":"2005","unstructured":"Haass NK, Herlyn M (2005) Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 10(2):153\u2013163","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"3","key":"2557_CR8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0749.2005.00235.x","volume":"18","author":"NK Haass","year":"2005","unstructured":"Haass NK, Smalley KS, Li L, Herlyn M (2005) Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res Spons Eur Soc Pigment Cell Res Int Pigment Cell Soc 18(3):150\u2013159","journal-title":"Pigment Cell Res Spons Eur Soc Pigment Cell Res Int Pigment Cell Soc"},{"issue":"1","key":"2557_CR9","doi-asserted-by":"crossref","first-page":"e53087","DOI":"10.1371\/journal.pone.0053087","volume":"8","author":"S Attoub","year":"2013","unstructured":"Attoub S, Arafat K, Gelaude A, Al Sultan MA, Bracke M, Collin P, Takahashi T, Adrian TE, De Wever O (2013) Frondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis. PLoS One 8(1):e53087","journal-title":"PLoS One"},{"issue":"2","key":"2557_CR10","first-page":"467","volume":"12","author":"YW Huang","year":"1997","unstructured":"Huang YW, Baluna R, Vitetta ES (1997) Adhesion molecules as targets for cancer therapy. Histol Histopathol 12(2):467\u2013477","journal-title":"Histol Histopathol"},{"issue":"10","key":"2557_CR11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.cellbi.2009.06.027","volume":"33","author":"Y Yamazoe","year":"2009","unstructured":"Yamazoe Y, Tsubaki M, Matsuoka H, Satou T, Itoh T, Kusunoki T, Kidera Y, Tanimori Y, Shoji K, Nakamura H, Ogaki M, Nishiura S, Nishida S (2009) Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cells. Cell Biol Int 33(10):1087\u20131094","journal-title":"Cell Biol Int"},{"issue":"31","key":"2557_CR12","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/onc.2009.139","volume":"28","author":"S Mori","year":"2009","unstructured":"Mori S, Chang JT, Andrechek ER, Matsumura N, Baba T, Yao G, Kim JW, Gatza M, Murphy S, Nevins JR (2009) Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene 28(31):2796\u20132805","journal-title":"Oncogene"},{"issue":"1\u20132","key":"2557_CR13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drup.2009.12.001","volume":"13","author":"A Abdollahi","year":"2010","unstructured":"Abdollahi A, Folkman J (2010) Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. Drug Resist Update Rev Comment Antimicrob Anticancer Chemother 13(1\u20132):16\u201328","journal-title":"Drug Resist Update Rev Comment Antimicrob Anticancer Chemother"},{"issue":"2\u20133","key":"2557_CR14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0163-7258(00)00053-X","volume":"87","author":"J Spychala","year":"2000","unstructured":"Spychala J (2000) Tumor-promoting functions of adenosine. Pharmacol Ther 87(2\u20133):161\u2013173","journal-title":"Pharmacol Ther"},{"issue":"8","key":"2557_CR15","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1158\/0008-5472.CAN-10-4246","volume":"71","author":"J Stagg","year":"2011","unstructured":"Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, Smyth MJ (2011) CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res 71(8):2892\u20132900","journal-title":"Cancer Res"},{"issue":"21","key":"2557_CR16","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1158\/0008-5472.CAN-12-1600","volume":"72","author":"F Virgilio Di","year":"2012","unstructured":"Di Virgilio F (2012) Purines, purinergic receptors, and cancer. Cancer Res 72(21):5441\u20135447","journal-title":"Cancer Res"},{"key":"2557_CR17","author":"AS Soares","year":"2014","unstructured":"Soares AS, Costa VM, Diniz C, Fresco P (2014) Inosine strongly enhances human C32 melanoma cells proliferation through PLC-PKC-MEK1\/2-ERK1\/2 and PI3K pathways. Basic Clin Pharmacol Toxicol. doi: 10.1111\/bcpt.12280","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2557_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1385\/MO:21:2:187","volume":"21","author":"D Vannoni","year":"2004","unstructured":"Vannoni D, Bernini A, Carlucci F, Civitelli S, Di Pietro MC, Leoncini R, Rosi F, Tabucchi A, Tanzini G, Marinello E (2004) Enzyme activities controlling adenosine levels in normal and neoplastic tissues. Med Oncol 21(2):187\u2013195","journal-title":"Med Oncol"},{"key":"2557_CR19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev.pharmtox.41.1.775","volume":"41","author":"J Linden","year":"2001","unstructured":"Linden J (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41:775\u2013787","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"2557_CR20","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.6061\/clinics\/2012(12)15","volume":"67","author":"N Pirincci","year":"2012","unstructured":"Pirincci N, Gecit I, Gunes M, Yuksel MB, Kaba M, Tanik S, Demir H, Aslan M (2012) Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer. Clinics 67(12):1443\u20131446","journal-title":"Clinics"},{"issue":"10","key":"2557_CR21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.clinbiochem.2005.05.015","volume":"38","author":"M Aghaei","year":"2005","unstructured":"Aghaei M, Karami-Tehrani F, Salami S, Atri M (2005) Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities. Clin Biochem 38(10):887\u2013891","journal-title":"Clin Biochem"},{"issue":"1\u20132","key":"2557_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-012-1513-6","volume":"374","author":"D Zanini","year":"2013","unstructured":"Zanini D, Schmatz R, Pelinson LP, Pimentel VC, da Costa P, Cardoso AM, Martins CC, Schetinger CC, Baldissareli J, do Carmo Araujo M, Oliveira L, Chiesa J, Morsch VM, Leal DB, Schetinger MR (2013) Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer. Mol Cell Biochem 374(1\u20132):137\u2013148","journal-title":"Mol Cell Biochem"},{"key":"2557_CR23","doi-asserted-by":"crossref","first-page":"326809","DOI":"10.5402\/2012\/326809","volume":"2012","author":"A Shafy","year":"2012","unstructured":"Shafy A, Molinie V, Cortes-Morichetti M, Hupertan V, Lila N, Chachques JC (2012) Comparison of the effects of adenosine, inosine, and their combination as an adjunct to reperfusion in the treatment of acute myocardial infarction. ISRN Cardiol 2012:326809","journal-title":"ISRN Cardiol"},{"issue":"3","key":"2557_CR24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1098-2787(1998)17:3<131::AID-MAS1>3.0.CO;2-O","volume":"17","author":"KH Schram","year":"1998","unstructured":"Schram KH (1998) Urinary nucleosides. Mass Spectrom Rev 17(3):131\u2013251","journal-title":"Mass Spectrom Rev"},{"issue":"3","key":"2557_CR25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/mol.65.3.711","volume":"65","author":"S Gessi","year":"2004","unstructured":"Gessi S, Varani K, Merighi S, Cattabriga E, Avitabile A, Gavioli R, Fortini C, Leung E, Mac Lennan S, Borea PA (2004) Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. Mol Pharmacol 65(3):711\u2013719","journal-title":"Mol Pharmacol"},{"issue":"1\u20132","key":"2557_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363","journal-title":"J Immunol Methods"},{"issue":"2","key":"2557_CR27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2):329\u2013333","journal-title":"Nat Protoc"},{"issue":"4","key":"2557_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/1541-7786.MCR-06-0353","volume":"5","author":"P Chaturvedi","year":"2007","unstructured":"Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK (2007) MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res 5(4):309\u2013320","journal-title":"Mol Cancer Res"},{"issue":"29","key":"2557_CR29","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/onc.2009.129","volume":"28","author":"L Taliaferro-Smith","year":"2009","unstructured":"Taliaferro-Smith L, Nagalingam A, Zhong D, Zhou W, Saxena NK, Sharma D (2009) LKB1 is required for adiponectin-mediated modulation of AMPK-S6\u00a0K axis and inhibition of migration and invasion of breast cancer cells. Oncogene 28(29):2621\u20132633","journal-title":"Oncogene"},{"issue":"1","key":"2557_CR30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nprot.2011.435","volume":"7","author":"M Baker","year":"2012","unstructured":"Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D\u2019Amico G, Jones DT, Vojnovic B, Hodivala-Dilke K (2012) Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 7(1):89\u2013104","journal-title":"Nat Protoc"},{"issue":"11","key":"2557_CR31","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1172\/JCI119833","volume":"100","author":"X Jin","year":"1997","unstructured":"Jin X, Shepherd RK, Duling BR, Linden J (1997) Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Investig 100(11):2849\u20132857","journal-title":"J Clin Investig"},{"issue":"4","key":"2557_CR32","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1073\/pnas.0908801107","volume":"107","author":"J Stagg","year":"2010","unstructured":"Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, Dwyer KM, Smyth MJ (2010) Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci USA 107(4):1547\u20131552","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2557_CR33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1523-1747.2002.00111.x","volume":"119","author":"S Merighi","year":"2002","unstructured":"Merighi S, Mirandola P, Milani D, Varani K, Gessi S, Klotz KN, Leung E, Baraldi PG, Borea PA (2002) Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Invest Dermatol 119(4):923\u2013933","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2557_CR34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00210-004-1012-8","volume":"371","author":"C Wolber","year":"2005","unstructured":"Wolber C, Fozard JR (2005) The receptor mechanism mediating the contractile response to adenosine on lung parenchymal strips from actively sensitised, allergen-challenged Brown Norway rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 371(2):158\u2013168","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"3","key":"2557_CR35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13105-012-0222-7","volume":"69","author":"P Mlejnek","year":"2013","unstructured":"Mlejnek P, Dolezel P, Frydrych I (2013) Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. J Physiol Biochem 69(3):405\u2013417","journal-title":"J Physiol Biochem"},{"issue":"3","key":"2557_CR36","doi-asserted-by":"crossref","first-page":"e32955","DOI":"10.1371\/journal.pone.0032955","volume":"7","author":"L Mervic","year":"2012","unstructured":"Mervic L (2012) Time course and pattern of metastasis of cutaneous melanoma differ between men and women. PLoS One 7(3):e32955","journal-title":"PLoS One"},{"issue":"17","key":"2557_CR37","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1158\/0008-5472.CAN-11-0025","volume":"71","author":"AA Ahmed","year":"2011","unstructured":"Ahmed AA, Wang X, Lu Z, Goldsmith J, Le XF, Grandjean G, Bartholomeusz G, Broom B, Bast RC Jr (2011) Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. Cancer Res 71(17):5806\u20135817","journal-title":"Cancer Res"},{"issue":"2","key":"2557_CR38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2008.12.073","volume":"379","author":"TA Tran","year":"2009","unstructured":"Tran TA, Gillet L, Roger S, Besson P, White E, Le Guennec JY (2009) Non-anti-mitotic concentrations of taxol reduce breast cancer cell invasiveness. Biochem Biophys Res Commun 379(2):304\u2013308","journal-title":"Biochem Biophys Res Commun"},{"issue":"35","key":"2557_CR39","doi-asserted-by":"crossref","first-page":"27213","DOI":"10.1074\/jbc.M109.087791","volume":"285","author":"Y Ohkawa","year":"2010","unstructured":"Ohkawa Y, Miyazaki S, Hamamura K, Kambe M, Miyata M, Tajima O, Ohmi Y, Yamauchi Y, Furukawa K, Furukawa K (2010) Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J Biol Chem 285(35):27213\u201327223","journal-title":"J Biol Chem"},{"issue":"3","key":"2557_CR40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.cmr.0000215030.69823.11","volume":"16","author":"R Sadej","year":"2006","unstructured":"Sadej R, Spychala J, Skladanowski AC (2006) Expression of ecto-5\u2032-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res 16(3):213\u2013222","journal-title":"Melanoma Res"},{"issue":"2","key":"2557_CR41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/1028602021000054973","volume":"5","author":"F Wang","year":"2003","unstructured":"Wang F, Cao Y, Liu HY, Xu SF, Han R (2003) Anti-invasion and anti-angiogenesis effect of taxol and camptothecin on melanoma cells. J Asian Nat Prod Res 5(2):121\u2013129","journal-title":"J Asian Nat Prod Res"},{"issue":"2","key":"2557_CR42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cbi.2009.06.019","volume":"181","author":"C Locatelli","year":"2009","unstructured":"Locatelli C, Leal PC, Yunes RA, Nunes RJ, Creczynski-Pasa TB (2009) Gallic acid ester derivatives induce apoptosis and cell adhesion inhibition in melanoma cells: the relationship between free radical generation, glutathione depletion and cell death. Chem Biol Interact 181(2):175\u2013184","journal-title":"Chem Biol Interact"},{"issue":"21","key":"2557_CR43","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1016\/j.bmc.2010.08.057","volume":"18","author":"AA Sallam","year":"2010","unstructured":"Sallam AA, Ramasahayam S, Meyer SA, El Sayed KA (2010) Design, synthesis, and biological evaluation of dibromotyrosine analogues inspired by marine natural products as inhibitors of human prostate cancer proliferation, invasion, and migration. Bioorgan Med Chem 18(21):7446\u20137457","journal-title":"Bioorgan Med Chem"},{"issue":"1","key":"2557_CR44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1634\/theoncologist.2012-0211","volume":"18","author":"SM Stemmer","year":"2013","unstructured":"Stemmer SM, Benjaminov O, Medalia G, Ciuraru NB, Silverman MH, Bar-Yehuda S, Fishman S, Harpaz Z, Farbstein M, Cohen S, Patoka R, Singer B, Kerns WD, Fishman P (2013) CF102 for the treatment of hepatocellular carcinoma: a phase I\/II, open-label, dose-escalation study. Oncologist 18(1):25\u201326","journal-title":"Oncologist"},{"issue":"20","key":"2557_CR45","doi-asserted-by":"crossref","first-page":"19516","DOI":"10.1074\/jbc.M413772200","volume":"280","author":"S Merighi","year":"2005","unstructured":"Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, Maclennan S, Borea PA (2005) A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase\/Akt-dependent inhibition of the extracellular signal-regulated kinase 1\/2 phosphorylation in A375 human melanoma cells. J Biol Chem 280(20):19516\u201319526","journal-title":"J Biol Chem"},{"issue":"36","key":"2557_CR46","doi-asserted-by":"crossref","first-page":"34548","DOI":"10.1074\/jbc.M305797200","volume":"278","author":"SR Conner","year":"2003","unstructured":"Conner SR, Scott G, Aplin AE (2003) Adhesion-dependent activation of the ERK1\/2 cascade is by-passed in melanoma cells. J Biol Chem 278(36):34548\u201334554","journal-title":"J Biol Chem"},{"key":"2557_CR47","author":"N Romanchikova","year":"2013","unstructured":"Romanchikova N, Trapencieris P, Zemitis J, Turks M (2013) A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1\/2 phosphorylation. J Enzyme Inhib Med Chem. doi: 10.3109\/14756366.2013.855207","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"2557_CR48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1593\/neo.04364","volume":"7","author":"S Bar-Yehuda","year":"2005","unstructured":"Bar-Yehuda S, Madi L, Silberman D, Gery S, Shkapenuk M, Fishman P (2005) CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model. Neoplasia 7(1):85\u201390","journal-title":"Neoplasia"},{"issue":"2","key":"2557_CR49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.currproblcancer.2006.12.002","volume":"31","author":"SY Sung","year":"2007","unstructured":"Sung SY, Hsieh CL, Wu D, Chung LW, Johnstone PA (2007) Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Curr Probl Cancer 31(2):36\u2013100","journal-title":"Curr Probl Cancer"},{"issue":"1","key":"2557_CR50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2013.06.040","volume":"437","author":"GD Kim","year":"2013","unstructured":"Kim GD, Oh J, Jeong LS, Lee SK (2013) Thio-Cl-IB-MECA, a novel A(3) adenosine receptor agonist, suppresses angiogenesis by regulating PI3K\/AKT\/mTOR and ERK signaling in endothelial cells. Biochem Biophys Res Commun 437(1):79\u201386","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2557-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2557-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:11:41Z","timestamp":1559038301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2557-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2557"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2557-y","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]}}}